Literature DB >> 8778276

Amyloid associated muscle pseudohypertrophy: amelioration of motor dysfunction with plasmapheresis and dimethylsulphoxide.

A Komiyama, M Kijima, M Takahashi, S Ishida, Y Ono.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8778276      PMCID： PMC486385          DOI： 10.1136/jnnp.60.5.591

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  A simple method for tissue pressure determination.

Authors:  T E Whitesides; T C Haney; H Harada; H E Holmes; K Morimoto
Journal:  Arch Surg       Date:  1975-11

2.  Skeletal muscle pseudohypertrophy in primary amyloidosis.

Authors:  J N Whitaker; K Hashimoto; M Quinones
Journal:  Neurology       Date:  1977-01       Impact factor: 9.910

3.  Primary systemic amyloidosis. A case permitting pathological and biochemical investigations.

Authors:  K Miyasaki; S Murao; S Tsunetoshi; N Koizumi; T Isobe; N Nakamura; H Nakano; T Ogino; S Hosokawa
Journal:  Acta Pathol Jpn       Date:  1979-01

4.  Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.

Authors:  C Jacquot; J P Saint-Andre; G Touchard; D Nochy; C D'Auzac de Lamartinie; R Oriol; P Druet; J Bariety
Journal:  Clin Nephrol       Date:  1985-08       Impact factor: 0.975

Review 5.  Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245
  5 in total
  1 in total

1.  Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report.

Authors:  Mirela Draghici; Andreea Jercan; Sorina Nicoleta Badelita; Ruxandra Maria Irimia; Alexandra Eugenia Bastian; Camelia Dobrea; Monica Popescu; Daniel Coriu
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.